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In cardiomyocytes, connexin 43 (Cx43) forms gap junctions and unopposed hemichannels
at the plasma membrane, but the protein is also present at the inner membrane of
subsarcolemmal mitochondria (SSM). Both inhibition and genetic ablation of Cx43 reduce
ADP-stimulated complex 1 respiration. Since mitochondrial potassium inﬂux impacts on
oxygen consumption, we investigated whether or not inhibition or ablation of mitochondrial
Cx43 alters mitochondrial potassium uptake. SSM were isolated from rat left ventricular
myocardium and loaded with the potassium-sensitive dye PBFI (potassium-binding benzo-
furan isophthalate). Intramitochondrial potassium was replaced by tetraethylammonium.
Mitochondria were incubated under control conditions or treated with 250 μM Gap19,
a peptide that speciﬁcally inhibits Cx43-based hemichannels at plasma membranes.
Subsequently, 140 mM KCl was added and the slope of the increase in PBFI ﬂuorescence
over time was calculated. The slope of the PBFI ﬂuorescence of the control mitochondria
was set to 100%. In the presence of Gap19, the mitochondrial potassium inﬂux was
reduced from 100 ± 11.6% in control mitochondria to 65.5 ± 10.7% (n = 6, p < 0.05).
In addition to the pharmacological inhibition of Cx43, potassium inﬂux was studied in
mitochondria isolated from conditional Cx43 knockout mice. Here, the ablation of Cx43
was achieved by the injection of 4-hydroxytamoxifen (4-OHT; Cx43Cre-ER(T)/ﬂ 4-OHT). The
mitochondria of the Cx43Cre-ER(T)/ﬂ
+
+ 4-OHT mice contained 3 ± 1% Cx43 (n = 6) of that
in control mitochondria (100 ± 11%, n = 8, p < 0.05). The ablation of Cx43 (n = 5) reduced
the velocity of the potassium inﬂux from 100 ± 11.2% in control mitochondria (n = 9)
to 66.6 ± 5.5% (p < 0.05). Taken together, our data indicate that both pharmacological
inhibition and genetic ablation of Cx43 reduce mitochondrial potassium inﬂux.
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INTRODUCTION
Connexin 43 (Cx43) forms gap junctions between adjacent car-
diomyocytes and is thus essential for cell–cell communication. Six
Cx43 proteins at the plasmamembrane assemble into a hemichan-
nel, and hemichannels open during ischemia and thereby con-
tribute to cell injury (Shintani-Ishida et al., 2007; Clarke et al.,
2009). Additionally, Cx43 is present at the innermembrane of car-
diomyocyte mitochondria, and cross-linking studies suggest the
presence of Cx43-hemichannels within cardiomyocyte mitochon-
dria (Miro-Casas et al., 2009). However, not all cardiomyocyte
mitochondria contain Cx43. In contrast to subsarcolemmal mito-
chondria (SSM), interﬁbrillar mitochondria (IFM) lack Cx43
(Boengler et al., 2009). An analysis of the impact of Cx43 on
mitochondrial function revealed reduced oxygen consumption
in mitochondria in which Cx43 was either inhibited by 18α-
glycyrrhetinic acid (18αGA)orCx43-mimetic peptides or inwhich
Cx43 was deleted by conditional knockout (Boengler et al., 2012).
Sincemitochondrial potassiumﬂuxes are important for the car-
dioprotection by ischemic pre- and postconditioning (O’Rourke,
2004; Boengler et al., 2011) and ischemic preconditioning depends
on Cx43 (Schwanke et al., 2002), the impact of Cx43 on mito-
chondrial potassium uptake was studied. In permeabilized wild-
type mouse cardiomyocytes, mitochondrial potassium inﬂux
was reduced by 18αGA. Also, the replacement of Cx43 by
Cx32 – a connexin which forms channels with lower potas-
sium conductance (Harris, 2002) – decreased the potassium
inﬂux into permeabilized murine cardiomyocytes (Miro-Casas
et al., 2009). In astrocytes, which also contain mitochondrial
Cx43, the administration of the Cx43 inhibitors carbenox-
olone and 18αGA reduced mitochondrial potassium uptake
(Kozoriz et al., 2010).
In the present study, we investigated the importance of Cx43
for potassium uptake in isolated cardiac mitochondria rather than
in intact cardiomyocytes. We studied potassium inﬂux in isolated
wild-type mouse mitochondria that were treated with Gap19, a
novel peptide which speciﬁcally targets Cx43-based hemichan-
nels. In addition, mitochondria isolated from conditional Cx43
knockout mice were investigated.
MATERIALS AND METHODS
ANIMALS
The present study was performed with approval by the Bioethi-
cal Committee of the State of Nordrhein-Westfalen, Germany. It
conforms to the Guide for the Care and Use of Laboratory Ani-
mals published by the US National Institutes of Health (NIH
publication No. 85-23, revised 1996).
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A dose of 3 mg 4-hydroxytamoxifen (4-OHT) was injected
daily for ﬁve consecutive days in Cx43Cre-ER(T)/ﬂ mice in which
one Cx43 allele had been replaced by the tamoxifen-inducible Cre
recombinase. The mice were sacriﬁced on day 11 after the ﬁrst
injection and mitochondria were isolated from the left ventricles.
4-OHT-treated Cx43ﬂ/ﬂ mice served as a control for potassium
measurements, and untreated Cx43ﬂ/ﬂ mice were used as a control
for Western blot analysis.
Experiments on the effects of Gap19 on potassium uptake were
performed in SSM and IFM from C57/Bl6 mice.
ISOLATION OF MITOCHONDRIA
Subsarcolemmal mitochondria were isolated as previously
described (Boengler et al., 2005). In brief, ventricles were minced
in isolation buffer [in mM: sucrose 250; 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) 10; ethylene glycol
tetraacetic acid (EGTA) 1; 0.5% bovine serum albumin (BSA); pH
7.4], homogenized with an Ultra Turrax, and centrifuged at 700 g
for 10 min. The resulting supernatant was centrifuged at 10,780 g
for 10 min, and the mitochondrial sediment was re-suspended in
isolation buffer without BSA and centrifuged at 7,650 g for 10min.
The protein concentration of the isolatedmitochondria was deter-
mined using the Dc protein assay (Bio-Rad, Hercules, CA, USA)
with BSA as standard. ForWestern blot analysis, the mitochondria
were further puriﬁed by Percoll gradient ultracentrifugation (30%
Percoll in isolation buffer, 34,000 g, 30 min).
Subsarcolemmal mitochondria and IFM were isolated as
already described (Boengler et al., 2009). Ventricular tissue was
washed in buffer A [in mM: KCl 100, 3-(N-morpholino)-
propanesulfonic acid (MOPS) 50, MgSO4 5, ATP 1, EGTA 1, pH
7.4] and weighed. Ventricles were minced in 10 ml/g buffer B
(buffer A + 0.04% BSA). The homogenate was centrifuged for
10 min at 800 g and the resulting supernatant (for SSM isola-
tion) for 10 min at 8,000 g. The sediment was re-suspended in
buffer A, washed, and re-suspended in a small volume of buffer A.
The sediment of the ﬁrst centrifugation (used for isolation of IFM)
was re-suspended in buffer B (10ml/g tissue). Nagarse (8 U/g) was
added and incubated for 1min on ice. The tissuewas homogenized
and centrifuged for 10 min at 800 g. The supernatant was cen-
trifuged for 10 min at 8,000 g. The mitochondria in the sediment
were re-suspended, washed in buffer A, and ﬁnally re-suspended
in a small volume of buffer A.
MITOCHONDRIAL POTASSIUM INFLUX
Mitochondria were loaded with 10 μM PBFI-AM [acetoxymethyl
ester of PBFI (potassium-binding benzofuran isophthalate);
Sigma-Aldrich, Heidenheim, Germany] diluted 2:1 with 20%
pluronic F127 for 10 min at 25◦C according to the protocol by
Costa et al. (2006). Three volumes of tetraethylammonium (TEA)
buffer (in mM: sucrose 175, TEA-Cl 50, HEPES 10, pyruvate 5,
malate 5, succinate 5, Pi 5, EGTA 0.1, and MgCl2 0.5 for exper-
iments with conditional Cx43 knockout mitochondria; TEA-Cl
120, HEPES 10, succinate 10, Na2HPO4 5, EGTA 0.1, MgCl2 0.5,
rotenone 5μM,oligomycin 0.67μM,pH 7.2 for experiments with
Gap19) were added, and the mitochondria were incubated for
2 min. Subsequently, the mitochondria were washed twice in iso-
lation buffer and the protein concentration was measured using
the Dc protein assay (Bio-Rad, Hercules, CA, USA). A sample of
200 μg mitochondrial proteins (SSM and IFM) was incubated for
30 min at 4◦C with 250 μM of the Cx43-hemichannel blocking
peptide Gap19 or under control conditions. In addition, untreated
mitochondria from Cx43ﬂ/ﬂ and Cx43Cre-ER(T)/ﬂ + 4-OHT mice
(SSM)were studied.Mitochondria (100μg/ml) were added to iso-
lation buffer supplemented with 1 μg/ml oligomycin (inhibits the
ATP synthase), 50 μM glibenclamide (blocks the mitochondrial
ATP-dependent potassium channel; control and conditional Cx43
knockout mice), and 1 μM cyclosporin A (inhibits opening of the
mitochondrial permeability transition pore; Gap19 experiments).
The uptake of potassium into the mitochondria was induced by
adding 140 mM KCl. The PBFI ﬂuorescence was measured in a
Cary Eclipse Fluorescence Spectrophotometer (Varian, Mulgrave,
Australia) at alternating excitation wavelengths of 340 (maximum
potassium sensitivity of the probe) and 380 nm (isosbestic point
of the probe), respectively, and an emission wavelength of 500 nm
at 25◦C. The maximal slope of the PBFI ﬂuorescence after the
KCl pulse was determined, and the maximal slope for the control
mitochondria was set to 100%.
WESTERN BLOT ANALYSIS
Mitochondrial proteinswere extracted in 1×Cell Lysis Buffer [Cell
Signaling, Beverly, MA, USA, containing in mM: Tris 20, NaCl
150, ethylenediaminetetraacetic acid (EDTA) 1, EGTA 1, sodium
pyrophosphate 2.5, β-glycerolphosphate 1, Na3VO4 1, phenyl-
methanesulfonyl ﬂuoride (PMSF) 1, 1μg/ml leupeptin, 1%Triton
X-100, pH 7.5, supplemented with complete protease inhibitors
(Roche, Basel, Switzerland)]. After centrifugation at 13,000 g for
10min at 4◦Cthe supernatantswere collected, and theprotein con-
centrations were determined using the Dc protein assay (Bio-Rad,
Hercules, CA, USA). Right ventricular or mitochondrial proteins
(20 μg) were electrophoretically separated on 10% SDS-PAGE
(sodium dodecyl sulfate-polyacrylamide gel electrophoresis) and
transferred to nitrocellulose membranes. After blocking, the
membranes were incubated with rabbit polyclonal anti-rat Cx43
(Invitrogen, Carlsbad, CA,USA) or rabbit-polyclonal anti-human
manganese superoxide dismutase (MnSOD, Upstate, Lake Placid,
NY,USA).After incubationwith the respective secondary antibod-
ies, immunoreactive signals were detected by chemiluminescence
(SuperSignal West Femto Maximum Sensitivity Substrate, Pierce,
Rockford, IL, USA) and quantiﬁed with the Scion Image software
(Frederick, MD, USA).
STATISTICS
Data are presented as mean values ± SEM. Western blot data and
the velocities of mitochondrial potassium uptake were compared
by Student’s t-test.
RESULTS
The velocity of the mitochondrial potassium inﬂux was measured
in wild-type SSM under control conditions and after incuba-
tion with 250 μM Gap19, a peptide that speciﬁcally inhibits
Cx43-based hemichannels at plasma membranes, at excitation
wavelengths of 340 and 380 nm, respectively (Figure 1). In
the presence of Gap19, the velocity of the mitochondrial potas-
sium inﬂux (340 nm) was reduced from 100 ± 11.6% in control
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FIGURE 1 | Mitochondrial potassium uptake is decreased by Gap19.
(A) Original traces showing PBFI ﬂuorescence in arbitrary units (a.u.) before
and after addition of 140 mM KCl of control- or Gap19-treated SSM at 340 and
380 nm excitation and 500 nm emission, respectively. (B) Bar graphs
represent the maximal slope of the PBFI ﬂuorescence at 340 nm excitation
and 500 nm emission of control and Gap19-treated mitochondria. *p < 0.05.
mitochondria to 65.5 ± 10.7% (n = 6, p < 0.05). At 380 nm
excitation, which represents the isosbestic point, the addition of
KCl did not affect the PBFI ﬂuorescence (6.5 ± 0.8% control vs.
7.8% ± 1.0% Gap19 treatment, n = 6, p = ns). In IFM, which
do not contain Cx43, Gap19 treatment had no inﬂuence on the
velocity of themitochondrial potassiumuptake (100± 11.8% IFM
control vs. 106.2 ± 22.2% IFM Gap19-treated, n = 5, p = ns).
The Cx43 content in SSM was determined in Cx43Cre-ER(T)ﬂ
mice treated with 4-OHT and in Cx43ﬂ/ﬂ control mice
(Figures 2A,B). Western blot analysis demonstrated a reduction
inmitochondrial Cx43 from 100± 10.7% in Cx43ﬂ/ﬂ mice (n = 8)
to 3.2 ± 1.1% in Cx43Cre-ER(T)/ﬂ + 4-OHTmice (n = 6, p< 0.05).
To exclude effects of 4-OHT treatment onmitochondrial function,
potassium inﬂux was measured in mitochondria isolated from 4-
OHT-treated Cx43ﬂ/ﬂ and Cx43Cre-ER(T)/ﬂ mice. The reduction of
the mitochondrial Cx43 content was associated with a reduction
in the maximal slope of the PBFI ﬂuorescence from 100 ± 11.2%
in Cx43ﬂ/ﬂ + 4-OHT mitochondria (n = 9) to 66.6 ± 5.5%
in Cx43Cre-ER(T)/ﬂ + 4-OHT mitochondria (n = 5, p < 0.05,
Figure 2C).
DISCUSSION
The present study addressed the role of Cx43 in mitochondrial
potassium uptake and demonstrated that both inhibition and
genetic ablation of mitochondrial Cx43 reduce the velocity of the
mitochondrial potassium inﬂux speciﬁcally in SSM.
FIGURE 2 | Genetic ablation of Cx43 reduces mitochondrial
potassium uptake. (A)Western blot analysis was performed for Cx43
and the mitochondrial marker protein MnSOD on proteins isolated from
SSM of Cx43ﬂ/ﬂ and Cx43Cre-ER(T)ﬂ + 4-OHT mice. (B) Bar graphs
represent the mitochondrial Cx43 content normalized to MnSOD in
Cx43ﬂ/ﬂ control mice, which were set to 100%, and 4-OHT-treated
Cx43Cre-ER(T)/ﬂ mice. *p < 0.05. (C) Bar graphs represent the maximal
slope of the PBFI ﬂuorescence at 340 nm excitation and 500 nm
emission of 4-OHT-treated Cx43ﬂ/ﬂ and Cx43Cre-ER(T)/ﬂ mitochondria.
*p < 0.05.
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The electrochemical gradient drives an inward potassium ﬂux
into mitochondria. For cardiac mitochondria, the ATP-dependent
potassium (mitoKATP) channel is of major importance. This chan-
nel is activated by pharmacological agents such as diazoxide,
whereas glibenclamide and ATP inhibit mitoKATP channel activ-
ity. The molecular identity of the mitoKATP channel has not yet
been deﬁnitely established. However, data suggest mitochondrial
localization of sarcolemmal potassium channel subunits (Ye et al.,
2009), and, most recently, the contribution of the ROMK (renal
outer medullary potassium channel) to the mitoKATP channel
(Foster et al., 2012).
Opening of the mitoKATP channel is important for the cardio-
protection afforded by ischemic preconditioning (O’Rourke, 2004;
Ardehali and O’Rourke, 2005), presumably via the formation of
low amounts of reactive oxygen species that function as signaling
molecules (Pain et al., 2000). Cx43 is involved in the cardiopro-
tection conferred by mitoKATP channel opening, since reactive
oxygen species formation and subsequent infarct size reduction
by diazoxide are lost in Cx43-deﬁcient mice (Heinzel et al., 2005).
The present study addressed the contribution of mitochon-
drial Cx43 to potassium inﬂux. Experiments were performed in
the presence of glibenclamide in order to allow the analysis of
putative Cx43-based channels and separate them from effects of
Cx43 on mitoKATP channels.
Previous data showed that in permeabilized mouse cardiomy-
ocytes Cx43 contributes to mitochondrial potassium uptake
(Miro-Casas et al., 2009). In this study, the Cx43 inhibitor 18αGA
was employed, and cardiomyocytes were used in which Cx43 had
been replaced byCx32. The aimof the present studywas to investi-
gate the importance of Cx43 formitochondrial potassium reﬁlling
in more detail. Therefore, isolated mitochondria from control
and conditional Cx43 knockout mice were used. The ablation of
Cx43 was achieved by the administration of 4-OHT, which may
impact on mitochondrial function, especially on mitochondrial
calcium homeostasis (Lobaton et al., 2005). However, previous
data demonstrated that the 4-OHT treatment used here has no
inﬂuence on mitochondrial oxygen consumption (Boengler et al.,
2012). To exclude putative effects of 4-OHT on mitochondrial
potassium uptake, data obtained in mitochondria from condi-
tional Cx43 knockoutmice were compared to those obtained from
4-OHT-treated control mice. Our data demonstrate that mito-
chondria that contain only minimal amounts of Cx43 (about 3%
of the amount of control mitochondria) have a reduced velocity of
potassium reﬁlling. Therefore, our data conﬁrm the importance
of Cx43 for mitochondrial potassium uptake.
In addition to the chronic scenario of the Cx43 knockout mice,
the acute situation was analyzed in which mitochondrial Cx43
was inhibited by Gap19. Gap19 is a peptide derived from nine
amino acids of the Cx43 cytoplasmic loop. This peptide inhibits
single channel Cx43-hemichannel currents at plasma membranes
but has no effect on gap junction channels or Cx40/pannexin-1-
dependent hemichannels as determined by calcium-induced ATP
release. Gap19 binds to the carboxy terminus of Cx43 and thereby
prevents interactions between the carboxy terminus and the cyto-
plasmic loop (Wang et al., 2013). In isolated cardiomyocytes,
Gap19 reduced cell swelling and cell death following simulated
ischemia/reperfusion and reduced infarct size in mouse hearts in
vivo (Wang et al., 2013). The speciﬁcity of Gap19 for Cx43-based
hemichannelsmakes this peptide an excellent tool to study the role
of Cx43 in mitochondrial potassium uptake. Since the carboxy
terminus of mitochondrial Cx43 is directed toward the intermem-
brane space (Boengler et al., 2009), Gap19 does not have to enter
the mitochondrial matrix in order to interact with Cx43.
In SSM isolated fromwild-typemice,Gap19 induced a decrease
in the velocity of mitochondrial potassium inﬂux. In IFM, which
do not contain Cx43 (Boengler et al., 2009), Gap19 had no effect,
demonstrating the speciﬁcity of the peptide for Cx43.
The present experiments were performed in the presence of
glibenclamide, which inhibits potassium ﬂuxes throughmitoKATP
channels (Inoue et al., 1991; Paucek et al., 1992); therefore, it is
unlikely that the delayed potassium inﬂux in Cx43-deﬁcient and
Gap19-treated mitochondria is due to effects of Cx43 on these
channels. However, several other channels also contribute to the
mitochondrial potassium cycle, among them calcium-dependent
potassium channels, the mitochondrial Kv1.3 potassium channel,
and the two-porepotassiumchannelTASK-3 (for review, see Szabo
et al., 2012). Since in the present study only total mitochondrial
potassium ﬂuxes were measured, it was not possible to distin-
guish whether mitochondrial potassium inﬂux occurs through
putative Cx43-based hemichannels or through an indirect mod-
ulation of the above mentioned potassium channels. Whether
or not mitochondrial Cx43 forms a channel similar to those at
the plasma membrane remains to be established. However, cross-
linking studies ofmitochondrial proteinswith subsequentWestern
blot analysis for Cx43 revealed immunoreactive signals at amolec-
ular weight typical for Cx43-based hexamers (Miro-Casas et al.,
2009).
Taken together, both the genetic ablation of Cx43 in condi-
tional knockout mice and the acute inhibition of mitochondrial
Cx43 by Gap19 demonstrate reduced velocities of mitochondrial
potassium uptake. These ﬁndings substantiate the impact of Cx43
on mitochondrial potassium ﬂuxes.
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